Abstract
Cholangiocarcinomas are malignant tumors that arise from the epithelium of the intrahepatic or extrahepatic bile ducts. Cholangiocarcinomas are rare compared with hepatocellular carcinoma, comprising less than 10% of primary malignancies of the liver (1). In the United States, approximately 3,000 patients are diagnosed with cholangiocarcinoma annually (2). The autopsy incidence of cholangiocarcinoma is low also, being reported in 0.089–0.46% of necropsies (1). Cholangiocarcinomas are diagnosed most frequently in the fifth and sixth decades of life (3). There is only a slight male preponderance of cases of cholangiocarcinoma. Cholangiocarcinomas can arise at any site in the intra- or extrahepatic biliary system, but perihilar tumors comprise two-thirds of the cases of cholangiocarcinoma (3) (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In MacSween RNM, Anthony PP, Scheuer PJ (eds). Pathology of the Liver, 2nd ed. Edinburgh: Churchill Livingstone, 1987, p. 574.
Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: A review. Gastroenterologist 5:306–315, 1997.
Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–475, 1996.
The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 54:1747–1755, 1984.
Sorensen HT, Friis S, Olsen JH, et al. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark. Hepatology 28:921–925, 1998.
Schwartz DA. Cholangiocarcinoma associated with liver fluke infection: A preventable source of morbidity in Asian immigrants. Am J Gastroenterol 81:76–79, 1986.
Kurathong S, Lerdverasirikul P, Wonkpaitoon V, et al. Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study. Gastroenterology 89:151–156, 1985.
Nakashima T, Okuda K, Kojiro M, et al. Primary liver cancer coincident with Schistosomiasis japonica. A study of 23 necropsies. Cancer 36:1483–1489, 1975.
Kim KH, Kim CD, Lee HS, et al. Biliary papillary hyperplasia with Clonorchiasis resembling cholangiocarcinoma. Am J Gastroenterol 94:514–517, 1999.
Nakanuma Y, Terada T, Tanka Y. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch A Pathol Anat Histopathol 406:45–58, 1985.
Thamavit W, Phamarapravati N, Sahaphong S, et al. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis vivemw-infected Syrian golden hamsters. Cancer Res 38:4634–4639, 1978.
Prempracha N, Tengchaisri T, Chawengkirttikul R, et al. Identification and potential use of a soluble tumor antigen for the detection of liver-fluke-associated cholangiocarcinoma induced in a hamster model. Int J Cancer 57:691–695, 1994.
Landais P, Drunfeld JP, Droz D, et al. Cholangiocellular carcinoma in polycystic kidney and liver disease. Arch Intern Med 144:2274–2276, 1984.
Voyles CR, Smadja C, Shands W, Blumgart LH. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg 118:986–988, 1983.
Imamura M, Miyashita T, Tani T, et al. Cholangiocellular carcinoma associated with multiple liver cysts. Am J Gastroenterol 79:790–795, 1984.
Dayton MT, Longmire WP, Tompkins RK. Caroli’s disease: A premalignant condition? Am J Surg 145:41–48, 1983.
Wee A, Ludwig L, Coffey RJ, et al. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 16:719–726, 1985.
Chen PH, Lo HW, Wang CS, et al. Cholangiocarcinoma in hepatolithiasis. J Clin Gastroenterol 6:539–547, 1984.
Koga A, Ichimiya H, Yamaguchi, et al. Hepatolithiasis associated with cholangiocarcinoma, possible etiologic significance. Cancer 55:2826–2829, 1985.
Yoshimoto H, Ikeda S, Tanaka M, Matsumoto S. Intrahepatic cholangiocarcinoma associated with hepatolithiasis. Gastrointest Endosc 31:260–263, 1985.
Chen MF, Jan YY, Wang CS, et al. A reappraisal of cholangiocarcinoma in patients with hepatolithiasis. Cancer 71:2461–2465, 1993.
Chijiiwa K, Ichimaya H, Kuroki S, et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet 177:279–282, 1993.
Robertson JF, Raine PA. Choledochal cyst: A 33 year review. Br J Surg 75:799–801, 1988.
Lipsett PA, Pitt HA, Colombani PM, et al. Choledochal cyst disease. A changing pattern of presentation. Ann Surg 220:644–652, 1994.
Cherqui D, Tantawi B, Alon R, et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118:615–619, 1995.
Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213:21–25, 1991.
Van Laethem JL, Deviere J, Bourgeois N, et al. Cholangiographie findings in deteriorating primary sclerosing cholangitis. Endoscopy 27:223–228, 1995.
Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19–9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68:874–879, 1993.
Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108:865–869, 1995.
Ito Y, Kojiro J, Nakashima T, Mori T. Pathomorphology characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma and hepatic angiosarcoma. Cancer 62:1153–1162, 1988.
Rubel LR, Ishak KG. Thorotrast-associated cholangiocarcinoma. An epidemiologic and clinicopathologic study. Cancer 50:1408–1415, 1982.
Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134:1347–1363, 1989.
Okada Y, Jinno K, Moriwaki S, et al. Expression of ABH and Lewis blood group antigens in combined hepatocellular-cholangiocarcinoma. Possible evidence for the hepatocellular origin of combined hepatocellular-cholangiocarcinoma. Cancer 60:345–352, 1985.
Goodman ZD, Ishak KG, Longloss JM, et al. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 55:124–135, 1985.
Ding SF, Delhanty JD, Bowles L, et al. Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma. Br J Cancer 67:1007–1010, 1993.
Sturm PDJ, Baas LO, Clement MJ, et al. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. Int J Cancer 78:695–698, 1998.
Wattanasirichaigoon S, Tasanakhajorn U, Jesadapatarakul S. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. J Med Assoc Thai 81:316–323, 1998.
Petmitr S, Pinlaor S, Thousungnoen A, et al. K-ras oncogene and p55 gene mutations in cholangiocarcinoma from Thai patients. Southeast Asian J trop Med Public Health 29:71–75, 1998.
Terada T, Ashida K, Endo K, et al. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. Histopathology 33:325–331, 1998.
Celli A, Que FG. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Sem Liver Dis 18:177–185, 1998.
Pitt H, Dooley W, Yeo C, Cameron J. Malignancies of the biliary tree. Curr Probl Surg 32:1–90, 1995.
Jalanko H, Kuusela P, Roberts P, et al. Comparison of a new tumor marker, CA 19–9T, with ot-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal disease. J Clin Pathol 37:218–222, 1984.
Oldenburg WA, Van Heerden PA, Sizemore GW, et al. Hypercalcemia and primary hepatic tumors. Arch Surg 117:1363–1366, 1992.
Davis JM, Sadasivan R, Dwyer T, et al. Case report: Cholangiocarcinoma and hypercalcemia. AM J Med Sei 307:350–352, 1994.
Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 139:217–238, 1983.
Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical features and computed tomographic findings. Hepatology 18:1090–1095, 1993.
Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarinoma? J Surg Oncol 69:162–167, 1998.
Bonetti F, Chilosi M, Posa R, et al. Epithelial membrane antigen expression in cholangiocarcinoma. A useful immunohistochemical tool for differential diagnosis with hepatocarcinoma. Virchows Arch A Pathol Anat Histopathol 401:307–313, 1983.
Pastolero GC, Wakabayashi T, Oka T, Mori S. Tissue polypeptide antigen: A marker antigen differentiating cholangiolar tumors from other hepatic tumors. Am J Clin Pathol 87:168–173, 1987.
Sasaki A, Kawano K, Aramaki M, et al. Immunohistochemical expression of cyto keratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver. J Surg Oncol 70:103–108, 1999.
Colli A, Cocciolo M, Mumoli N, et al. Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound 7:93–99, 1998.
Kuszyk BS, Soyer P, Bluemke DA, Fishman EK. Intrahepatic cholangiocarcinoma: The role of imaging in detection and staging. Critical Rev in Diag Imaging 38:59–88, 1997.
Feydy A, Vilgrain V, Denys A, et al. Helical CT assessment in hilar cholangiocarcinoma: Correlation with surgical and pathologic findings. AJR 172:73–77, 1999.
Tillich M, Mischinger HJ, Preisegger KH, et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR 171:651–658, 1998.
Han JK, Choi BI, Kim TK, Kim SW, Han MC, Yeon KM. Hilar cholangiocarcinoma: Thin-section spiral CT findings with Cholangiographie correlation. Radiographics 17:1475–1485, 1997.
Okuda K, Ohto M, Tsuchiya Y. The role of ultrasound, percutaneous transhepatic cholangiography, computed tomographic scanning, and magnetic resonance imaging in the preoperative assessment of bile duct cancer. World J Surg 12:18–26, 1988.
Garber ST, Donald J J, Lees WR. Cholangiocarcinoma: Ultrasound features and correlation of tumor position with survival. Abdom Imaging 18:66–69, 1993.
Neumaier CE, Bertolotto M, Perrone R, Martinoli C, et al. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 23:173–178, 1995.
Kusano T, Shimabukuro M, Tamai O, et al. The use of intraoperative ultrasonography for detecting tumor extension in bile duct carcinoma. Int Surg 82:44–48, 1997.
Fujita N, Noda Y, Kobayashi G, et al. Staging of bile duct carcinoma by EUSandlDUS. Endoscopy 30.A132-A 134, 1998.
Choi BI, Kim TK, Han JK. MRI of Clonorchiasis and cholangiocarcinoma. J MRI 8:359–366, 1998.
Worawattanakul S, Semelka RC, Noone TC, et al. Cholangiocarcinoma: Spectrum of appearances on MR images using current techniques. Magnetic Resonance Imaging 16:993–1003, 1998.
Neri E, Boraschi P, Braccini G, et al. MR virtual endoscopy of the pancreaticobiliary tract. Magnetic Resonance Imaging 17:59–67, 1999.
Elias E, Hamlyn AN, Jain S, et al. A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus ERCP for bile duct visualization in jaundice. Gastroenterology 71:439–443, 1976.
Tanaka M, Ogawa Y, Matsumoto S, et al. The role of endoscopic retrograde cholangiopancreatography in preoperative assessment of bile duct cancer. World J Surg 12:27–32, 1988.
Yamakawa T, Esguerra R, Kaneko H, et al. Percutaneous transhepatic endoprosthesis in malignant obstruction of the bile duct. World J Surg 12:78–84, 1988.
Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 201:545–553, 1985.
McPherson GAD, Benjamin IS, Hodjson HJF, et al. Preoperative percutaneous transhepatic biliary drainage: The results of a controlled trial. Br J Surg 71:371–375, 1984.
Cameron JL, Broe P, Zuidema GD. Proximal bile duct tumors: Surgical management with silastic transhepatic biliary stents. Ann Surg 196:412–419, 1982.
Crist DW, Kadir S, Cameron JL. The value of preoperatively placed percutaneous biliary catheters in reconstruction of the proximal part of the biliary tree. Surg Gynecol Obstet 165:421–424, 1987.
Soehendra N, Grimm H. Endoscopic retrograde drainage for bile duct cancer. World J Surg 12:85–90, 1988.
Keiding S, Hansen SB, Rasmussen HH, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28:700–706, 1998.
Voyles CR, Bowley NJ, Allison DJ, et al. Carcinoma of the proximal extrahepatic biliary tree, radiologic assessment and therapeutic alternatives. Ann Surg 197:188–194, 1983.
Van Delden OM, de Wit LT, van Dijkum EJ, et al. Value of laparoscopic ultrasonography in staging of proximal bile duct tumors. J Ultrasound Med 16:7–12, 1997.
Roayaie S, Guarrera JV, Ye MQ, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: Predictors of outcomes. J Am Coll Surg 187:365–372, 1998.
Lieser MJ, Barry K, Rowland C, et al. Surgical management of intrahepatic cholangiocarcinoma: A 31-year experience. J Hep Bil Pancr Surg 5:41–47, 1998.
Sixth report. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 60:1400–1411, 1987.
Liguory C, Canard JM. Tumours of the biliary system. Clin Gastroenterol 12:269–295, 1983.
Harrison LE, Fong Y, Klimstra DS, et al. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85:1068–1070, 1998.
Chou FF, Sheen-Chen SM, Chen CL, et al. Prognostic factors of resectable intrahepatic cholangiocarcinoma. J Surg Oncol 59:40–44, 1995.
Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 19:83–88, 1995.
Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: Mode of spread and choice of surgical treatment. Br J Surg 85:1206–1209, 1998.
Sansalone CV, Colella G, Caccamo L, et al. Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience. Transplant Proc 26:3561–3563, 1994.
Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 166:768–771, 1993.
Curley SA, Levin B, Rich TA. Liver and bile ducts. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds). Clinical Oncology. London: Churchill Livingston, 1995, p. 1305–1372.
Fardel D. Malignant neoplasms of the extrahepatic biliary ducts. Ann Surg 76:205–211, 1922.
Altmeier WA, Gall EA, Zinninger MM, et al. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 75:450–454, 1957.
Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med 38:241–248, 1965.
Sako K, Seitzinger GL, Garside E. Carcinoma of the extrahepatic bile ducts: Review of the literature and report of six cases. Surgery 41:416–422, 1957.
Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA-A Cancer Journal for Clinicians 49:8–31, 1999.
Bismuth H, Castaing D, Traynor O. Resection or palliation: Priority of surgery in the treatment of hilar cancer. World J Surg 12:39–47, 1988.
Nagorney DM, Donohue JH, Farnell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128:871–879, 1993.
Nimura Y, Kamiya J, Nagino M, et al. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hep Bil Pancr Surg 5:52–61, 1998.
Burke EC, Jarnigan WR, Hochwald SN, et al. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228:385–394, 1998.
Chung C, Bautista N, O’Connell TX. Prognosis and treatment of bile duct carcinoma. Am Surg 64:921–925, 1998.
Kayahara M, Nagakawa T, Ohta T, et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 229:76–83, 1999.
Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma. Ann Surg 194:447–457, 1981.
Ouchi K, Suzuki M, Hashimoto L, et al. Histologic findings and prognostic factors in carcinoma of the upper bile duct. Am J Surg 157:552–556, 1989.
Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: A histologic analysis of 62 resected cases. Ann Surg 227:405–411, 1998.
Mittal B, Deutsch M, Iwatsuki S. Primary cancers of the extrahepatic biliary passages. Int J Radiât Oncol Biol Phys 11:849–854, 1985.
Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 162:153–158, 1986.
Mizumoto R, Suzuki H. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. World J Surg 12:2–10, 1988.
Bengmark S, Ekberg H, Evander A, et al. Major liver resection for hilar cholangiocarcinoma. Ann Surg 207:120–125, 1988.
White TT. Skeletization resection and central hepatic resection in the treatment of bile duct cancer. World J Surg 12:48–51, 1988.
Pinson CW, Rossi RL. Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg 12:52–59, 1988.
Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130:270–276, 1995.
Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 217:20–27, 1993.
Nagino M, Nimura Y, Kamiya J, et al. Segmental liver resections for hilar cholangiocarcinoma. Hepatogastroenterology 45:7–13, 1998. 109.
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178, 1975.
Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134:261–266, 1999.
Tsukada K, Yoshida K, Aono T, Koyama S, Shirai Y, Uchida K, Muto T. Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg 81:108–110, 1994.
Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 159:91–98, 1990.
Alexandre JH, Dehni N, Bouillot JL. Stented hepaticojejunostomies after resection for cholangiocarcinoma allow access for subsequent diagnosis and therapy. Am J Surg 169:428–429, 1995.
McMasters KM, Turtle TM, Leach SD, et al. Neoadjuvant chemoradiation enhances margin-negative resection rates for extrahepatic cholangiocarcinoma. Am J Surg 174:605–609, 1997.
Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88–98, 1989.
O’Grady JG, Poison RJ, Rolles K, et al. Liver transplantation for malignant disease. Ann Surg 207:373–379, 1988.
Funovics JM, Fritsch A, Herbst F, et al. Primary hepatic cancer - the role of limited resection and total hepatectomy with orthotopic liver replacement. Hepatogastroenterology 35:316–320, 1988.
Iwatsuki S, Gordon RD, Shaw BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 202:401–407, 1985.
Koneru B, Cassavilla A, Bowman J, et al. Liver transplantation for malignant tumors. Gastroenterol Clin North Am 17:177–193, 1988.
Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–193, 1990.
Yokoyama I, Sheahan DG, Carr B, et al. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transpl Proc 24:2194–2196, 1991.
Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–1268, 1990.
Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 23(Suppl):S104-S109, 1989.
Margeiter R. Indications for liver transplantation for primary and secondary liver tumor. TransplProc 18(Suppl 3):74–80, 1986.
Angrisano L, Jurewicz WA, Clements DG, et al. Liver transplantation for liver cancer. TransplProc 18:1218–1225, 1986.
Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: The role of liver transplantation. Br J Surg 77:983–987, 1990.
Van Thiel DH, Carr B, Iwatsuki S, et al. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transpl Proc 23:1917–1921, 1991.
Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187:358–364, 1998.
Langer JC, Langer B, Taylor BR, et al. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery 98:752–759, 1985.
Lameris JS, Stoker J, Dees J, et al. Non-surgical palliative treatment of patients with malignant biliary obstruction - the place of endoscopic and percutaneous drainage. Clin Radiol 38:603–608, 1987.
Huibregtse K, Tytgat GN. Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut 23:371–375, 1982.
O’Brien S, Hatfield ARW, Carig PI, Williams SP. A three-year follow-up of self-expanding metal stents in the endosc, opic palliation of long term survivors with malignant biliary obstruction. Gut 36:618–621, 1995
Shim CS, Lee YH, Cho YD, et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 30:345–350, 1998.
Kubota Y, Takaoka M, Kin H, et al. Endoscopic irradiation and parallel arrangement of wallstents for hilar cholangiocarcinoma. Hepatogastroenterology 45:415–419, 1998.
Mueller PR, van Sonnenberg E, Ferrucci JT, Jr. Percutaneous biliary drainage: Technical and catheter-related problems in 200 procedures. AJR 138:17–23, 1982.
Lai ECS, Tompkins RK, Roslyn JJ, et al. Proximal bile duct cancer: Quality of survival. Ann Surg 205:111–118, 1987.
Malangoni MA, McCoy DM, Richardson JD, Flint LM. Effective palliation of malignant biliary duct obstruction. Ann Surg 201:554–559, 1985.
Nordaback IH, Pitt HA, Coleman J, Venbrux AC, et al. Unresectable hilar cholangiocarcinoma: Percutaneous versus operative palliation. Surgery 115:597–603, 1994.
Guthrie CM, Banting SW, Garden OJ, Carter DC. Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg 81:1639–1641, 1994.
Farley DR, Weaver AL, Nagorney DM.’Natural history’ of unresected cholangiocarcinoma: Patient outcome after noncurative intervention. Mayo Clin Proc 70:425–429, 1995.
Oberfield RA, Rossi RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 12:105–108, 1988.
Curley SA, Cameron JL. Hilar bile duct cancer: A diagnostic and therapeutic challenge. Cancer Bull 44:309–315, 1992.
Meyers WC, Jones RS. Internal radiation for bile duct cancer. World J Surg 12:99–104, 1988.
Karani J, Fletcher M, Brinkley D, et al. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 36:603–606, 1985.
Johnson DW, Safai C, Goffinet DR. Malignant obstructive jaundice: Treatment with external-beam and intracavity radiotherapy. Int J Radiât Biol Phys 11:411–416, 1985.
Mornex F, Ardiet JM, Bret P, et al. Radiotherapy of high bile duct carcinoma using intracatheter iridium 192 wire. Cancer 54:2069–2073, 1984.
Hishikawa Y, Shimada T, Miura T, et al. Radiation therapy of carcinoma of the extrahepatic bile ducts. Radiology 146:787–789, 1983.
Busse PM, Stone MD, Sheldon TA, et al. Intraoperative radiation therapy for biliary tract carcinoma: Results of a 5-year experience. Surgery 105:724–733, 1989.
Iwasaki Y, Todoroki T, Fukao K, et al. The role of intraoperative radiation therapy in the treatment of bile duct cancer. World J Surg 12:91–98, 1988.
Rich TA. Treatment planning for tumors of the gastrointestinal tract. In Paliwal BR, Griem ML (eds). Syllabus: A Categorical Course in Radiation Therapy Treatment Planning. Illinois: RSNA Division of Editorial and Publishing Services, 1986, p. 47.
Nunnerly HB. Interventional radiology and internal radiotherapy for bile duct tumors. In Preece PE, Cushieri A, Rosin RD (eds). Cancer of the Bile Ducts and Pancreas. Philadelphia: W.B. Saunders, 1989, p 93.
Rich TA. Intraoperative radiotherapy: A review. Radiother Oncol 6:207–221, 1986.
Deziel DJ, Kiel KD, Kramer TS, et al. Intraoperative radiation therapy in biliary tract cancer. Am Surg 54:402–407, 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Curley, S.A. (2001). Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. In: Talamonti, M.S., Pappas, S.G. (eds) Liver-Directed Therapy for Primary and Metastatic Liver Tumors. Cancer Treatment and Research, vol 109. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3371-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3371-6_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-3373-0
Online ISBN: 978-1-4757-3371-6
eBook Packages: Springer Book Archive